SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001136261-19-000013
Filing Date
2019-01-28
Accepted
2019-01-28 17:04:53
Documents
2
Period of Report
2019-01-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1536
2 POWER OF ATTORNEY poasmith.htm EX-24 4362
  Complete submission text file 0001136261-19-000013.txt   7442
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Issuer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASE III MEDICAL, INC. 330 SOUTH SERVICE ROAD, SUITE 120 MELVILLE NY 11747
Business Address
Smith Robin L (Reporting) CIK: 0001365035 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 19546226